Stem Cells Market Size & Share Report, Growth, Trends, 2032

Stem Cells Market

Stem Cells Market, By Product Type (Pluripotent Cells, Human Embryonic Stem Cells, Adult Stem Cells, and Others), By Source (Allogeneic, and Autologous), By Application (Development & Drug Discovery, and Regenerative Medicine), and By End User (Tissue & Cell Banks, Therapeutic Companies, Service Companies, and Reagent & Tools Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 – 2032-

Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-2620 Published Date: Sep-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 374.28 Million USD 878.21 Million 9.94% 2023

Stem Cells Market Insights

According to a report from Zion Market Research, the global Stem Cells Market was valued at USD 374.28 Million in 2023 and is projected to hit USD 878.21 Million by 2032, with a compound annual growth rate (CAGR) of 9.94% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Stem Cells industry over the next decade.

Global Stem Cells Market SizeRequest Free Sample

The stem cell is one of the master cells of the human body; it has the capability to develop into anyone’s body with more than 200 plus cell types. Stem cells are undifferentiated cells that typically belong to the same family category (lineage). They preserve the capability to divide all through life and give augment to cells that can turn out to be extremely specialized and take the place of cells that doesn’t grow. Stem cells add to the body's ability to repair and renew its tissues and generate new cells of any tissue they belong to.

Global Stem Cells Market: Growth Factors

One of the most significant aspects which are boosting the stem cell market expansion is the limitations in conventional organ transplantations. The rising concerns with organ transplantations have boosted the demand for stem cell treatment products. Conventional or traditional organ donation method is connected with immunosuppressant risk, infection risk, and negative response. Also, the demand for organs is growing, and physicians/doctors are completely dependent on organ donors. To rise above these issues several researchers are now discovering ways to recognize the application of stem cell therapies in different transplants. In addition, graft rejection can be decreased with the stem cells, as these are grown utilizing the same personal cells. These benefits in the transplantations of organs will result in the expansion of the global stem cell market in the future.

Stem Cells MarketRequest Free Sample

Global Stem Cells Market: Segmentation

The global stem cell market is classified based on sources, product type, end users, application, and geography. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on product type, the stem cell market is categorized into induced pluripotent cells, human embryonic stem cells, adult stem cells, and others.

Based on sources, the market is bifurcated into allogeneic and autologous. Based on application, the stem cells market is classified into development & drug discovery, and regenerative medicine.

Based on end users the market is divided into tissue & cell banks, therapeutic companies and service companies, and reagent & tools companies.

The Regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Stem Cells Market: Report Scope

Report Attributes Report Details
Report Name Stem Cells Market
Market Size in 2023 USD 374.28 Million
Market Forecast in 2032 USD 878.21 Million
Growth Rate CAGR of 9.94%
Number of Pages 110
Key Companies Covered Osiris Therapeutics Inc., STEMCELL Technologies Inc., BIOTIME, Inc., Celgene Corporation, Human Longevity Inc., Cynata, Cytori Therapeutics, Promethera Biosciences, and Advanced Cell Technology Inc., among others
Segments Covered By Sources, By Product Type, By End Users, By Application And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Stem Cells Market: Regional Analysis

Regionally, the global stem cells market is classified into North America, Asia Pacific, Europe, and the Middle East & Africa. North America is anticipated to dominate the market owing to the significant investments in this field, remarkable economic expansion, increasing instances of target chronic syndrome, and technological development. North America is followed by Europe and is estimated to grow at a significant rate in the years to come. Asia Pacific stem cells market is expected to develop at a rapid rate in the future; whereas the Middle East stem cells market is predicted to grow at a sluggish rate in the coming years.

Global Stem Cells Market: Competitive Players

Some of the major key players in the global stem cells market are Osiris Therapeutics Inc., STEMCELL Technologies Inc., BIOTIME, Inc., Celgene Corporation, Human Longevity Inc., Cynata, Cytori Therapeutics, Promethera Biosciences, and Advanced Cell Technology Inc., among others.

Global Stem Cells Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of The Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The Stem Cells Market was valued at USD 374.28 Million in 2023.

The Stem Cells Market is expected to reach USD 878.21 Million by 2032, growing at a CAGR of  9.94% between 2024 to 2032.

Global Stem Cells Market players such as Osiris Therapeutics Inc., STEMCELL Technologies Inc., BIOTIME, Inc., Celgene Corporation, Human Longevity Inc., Cynata, Cytori Therapeutics, Promethera Biosciences, and Advanced Cell Technology Inc., among others.

One of the most significant aspects which are boosting the stem cell market expansion is the limitations in conventional organ transplantations. The rising concerns with organ transplantations have boosted the demand for stem cell treatment products. Conventional or traditional organ donation method is connected with immunosuppressant risk, infection risk, and negative response. Also, the demand for organs is growing, and physicians/doctors are completely dependent on organ donors.

The Regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed